Overview

• Iga Swiatek tested positive for trimetazidine in August 2024, which was traced to contamination in her melatonin medication.
• The International Tennis Integrity Agency (ITIA) ruled her fault as minimal, leading to a one-month ban, but critics have questioned the leniency of the penalty.
• Simona Halep and other players have alleged preferential treatment, contrasting Swiatek's case with harsher bans for similar violations in the past.
• The World Anti-Doping Agency (WADA) is reviewing the ITIA's decision and may appeal to the Court of Arbitration for Sport (CAS) for stricter sanctions.
• Swiatek has defended her innocence, highlighting procedural differences in anti-doping cases and expressing trust in the ITIA's objectivity.